Lv6
3008 积分 2022-07-12 加入
Pharmacokinetic modeling frameworks for complex antibody-drug conjugates analytes: clinical pharmacology considerations
1天前
已完结
Advancing siRNA Therapeutics with Pharmacometrics: A Review ofModeling Approaches and Clinical Applications
2天前
已完结
A missed synthesis from the 1930s: Teorell, Mayneord, and the origins of physiological PK–TGI modelling
20天前
已完结
Epcoritamab Step‐Up Dosing Regimen Selection and Optimization Using Repeated Time‐to‐Event Modeling for Cytokine Release Syndrome Risk Mitigation
1个月前
已完结
Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review
1个月前
已完结
Model‐Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B‐Cell Lymphoma
1个月前
已完结
Target identification and assessment in the era of AI
3个月前
已完结
Strategic adoption of model-informed drug development (MIDD) as an overarching business model in biotechnology and life science industry
3个月前
已关闭
Racial/ethnic differences in survival and treatment response with PD-1/PD-L1 inhibitors in resectable non-small cell lung cancer: a meta-analysis of randomized controlled trials
4个月前
已完结
TMDD Modeling for Antibodies Directed Against Soluble Targets: Parameter Values for De Novo Modeling and Simulation From Experimental Data
4个月前
已完结
皖公网安备34019202002308
